Lv1
78 积分 2024-05-29 加入
Augmenting cancer therapy with a supramolecular immunogenic cell death inducer: a lysosome-targeted NIR-light-activated ruthenium (II) metallacycle
48分钟前
待确认
The fight against rheumatism: from willow bark to COX-1 sparing drugs
1个月前
已关闭
Discerning the Multi-dimensional Role of Salicin: Bioactive Glycoside Beyond Analgesic: Different Perspectives
1个月前
已完结
Platinum‐Metformin Conjugates Acting as Promising PD‐L1 Inhibitors through the AMP‐Activated Protein Kinase Mediated Lysosomal Degradation Pathway
1个月前
已完结
Anticancer Agents Beyond Cisplatin
2个月前
已完结
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
2个月前
已完结
Mechanisms driving the immunoregulatory function of cancer cells
2个月前
已完结
A review on the recent advances of interaction studies of anticancer metal-based drugs with therapeutic targets, DNA and RNAs
2个月前
已完结
Regulation of cGAS–STING signalling and its diversity of cellular outcomes
2个月前
已完结
Exploring the Future of Metal‐Based Anticancer Agents: A Comprehensive Review of Ruthenium‐Based Complexes
3个月前
已完结
皖公网安备34019202002308
